NCCN Issues Guideline Update on the Use of High-Dose Methotr

The National Comprehensive Cancer Network has announced a guideline update concerning the treatment of patients with acute lymphoblastic leukemia, B-cell lymphomas, pediatric ALL, and pediatric aggressive mature B-cell lymphoma.

Related Keywords

Ohio , United States , Cincinnati , Laura Ramsey , National Comprehensive Cancer Network , Cincinnati Children Hospital Medical Center , Medical Strategy , Cincinnati Children , Hospital Medical Center , Managing Toxicities , Clin Pharmacol , Patients With Newly Diagnosed Acute Lymphocytic Leukemia , Patients Withb Cell All , Nccn , High Dose Methotrexate , B Cell Lymphomas , Pediatric All , Glucarpidase ,